SYSTEMIC LUPUS ERYTHEMATOSUS IN HIV PATIENT: A CASE STUDY
PDF (Português (Brasil))

Keywords

Antiretrovirals, Patients Resistant to Treatment, Cooperation and Adequacy of Treatment, Immunosuppression, Infectology

How to Cite

SORIANO, C. C. B., BRASIL, D. D. S., CASTRO, M. S. D. N., ALMEIDA, Y. V. S., ESCOSSIO, E. F., SILVESTRE NETO, T., ROTILLI, G. K., MARINHO, D. T. D. S., SANTOS, J. C., RODRIGUEZ, P. C. R., & AZEVEDO, A. P. D. (2024). SYSTEMIC LUPUS ERYTHEMATOSUS IN HIV PATIENT: A CASE STUDY. Brazilian Journal of Implantology and Health Sciences, 6(2), 1523–1535. https://doi.org/10.36557/2674-8169.2024v6n2p1523-1535

Abstract

Introduction: The coexistence of Acquired Immunodeficiency Syndrome-AIDS with Lupus Erythematosus-SLE is extremely rare. In addition to clinical manifestations, a series of laboratory results can occur in both cases. Objective: To report a case of a patient immunosuppressed by HIV and with systemic lupos erythematosus. Methodology: This is a collection of existing secondary information on the electronic record of the study participant. Case study: Patient, female, 44 years old, living with HIV for 13 years, having abandoned treatment for about 3 months and co-infected with Systemic Lupus Erythematosus-SLE for 05 years with abandoning treatment for one year. Ao not soon admitting care from the referring hospital informs that for two weeks we have been feeling productive cough, hyperthermia, hemiparesis on the left with permanence of touch sensitivity, significant weight loss, hair remains itchy without hair. For about a week she has been presenting split plaques in the oropharynx associated with odynophagia and generalized asthenia. She has symptoms of kidney failure. Patient did not appear for outpatient consultations because she was bedridden and had no assistance for or transportation to the hospital. After support and hospitalization, the patient was transferred to the infirmary apparently lucid and oriented. In the hours following the same anuric syndrome occurred during the dialysis procedure, it was hemodynamically destabilized. Transferred to ICU. After 47 hours of intensive care, she presents cardiac arrest with clinical signs of death. Conclusion: Better support and guidance for these patients, from the first time they take medication or the first symptoms of aggravation during hospitalization, may be the greatest benefit to drug treatment

https://doi.org/10.36557/2674-8169.2024v6n2p1523-1535
PDF (Português (Brasil))

References

CAMPOS, J M E; ILVA, T M S; ERRANTE P R. Tratamento farmacológico no lúpus eritematoso sistêmico. Revista UNILUS Ensino e Pesquisa v. 14, n. 35, abr./jun. 2017. file:///C:/Users/33822280259/Downloads/788-2349-1-PB.pdf

MACDONALD TM, HAWKEY CJ, FORD I, et al. Randomized trial of switching from prescribed non-selective non-steroidal anti-inflammatory drugs to prescribed celecoxib: the standard care vs. Celecoxib Outcome Trial (SCOT). Eur Heart J. 2016 Oct 4. pii:ehw387. https://pubmed.ncbi.nlm.nih.gov/27705888/

RESENDE OLC, BARBOSA MTS, SIMÕES BFT, VELASQUE LS. A representação do adoecer em adolescentes com lúpus eritematoso sistêmico. rev bras reumatol . 201 6;56(5):398–405. https://www.scielo.br/j/rbr/a/7NhqrsCVfj7HfKRgZpMGGkk/?format=pdf&lang=pt

GUERREIRO M G U; SOUSA M N A. Qualidade de vida e sofrimento psíquico em mulheres com Lúpus Eritematoso Sistêmico. Revista Saúde e Desenvolvimento| vol.13, n.16, 2019. file:///C:/Users/33822280259/Downloads/1046-Texto%20do%20artigo-3334-3725-10-20200211.pdf

BRAGA, M. et al. Correlation between physical markers and psychiatric health in a Portuguese systemic lupus erythematosus cohort: The role of suffering in chronic autoimmune disease. Dados em PLOS ONE, Portugal, vol. 13, n. 4, 2018. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5901990/

ETCHEGARAY, I. et al. Factors Associated with Health-Related Quality of Life in Mexican Lupus Patients Using the Lupus Qol. Dados em PLOS ONE, v. 12, n. 1, 2017. https://journals.sagepub.com/doi/abs/10.1177/0961203317751062

FITZCARRALD, C. et al. Factors associated with health-related quality of life in Peruvian patients with systemic lupus erythematosus. Lupus, v. 27, n. 6, p. 913- 919, 2018. https://journals.sagepub.com/doi/abs/10.1177/0961203317751062

FERENTZ, L. Análise da qualidade de vida pelo método Whoqol-Bref: estudo de caso na cidade de Curitiba, Paraná. Revista Estudo & Debate, v. 24, n. 3, 2017. http://univates.br/revistas/index.php/estudoedebate/article/view/1359/0

MUHAMMED, H. et al. Neuropsychiatric manifestations are not uncommon in Indian lupus patients and negatively affect quality of life. Lupus, Índia, v. 27, n. 4, p. 688-693, 2018. https://pubmed.ncbi.nlm.nih.gov/29241417/

NOWICKA, K. et al. Illness perception is significantly determined by depression and anxiety in systemic lupus erythematosus. Lupus, v. 27, n. 3, p. 454-460, 2018. https://pubmed.ncbi.nlm.nih.gov/29325492/

REIS J V et al. Manifestações dermatológicas do lúpus eritematoso sistêmico e sua influência na qualidade de vida. Revista Eletrônica Acervo Médico. Vol.23(3), 2023. https://acervomais.com.br/index.php/medico/article/view/12095/7178

RODRIGUES, S.P.; NASCIMENTO, M.S.; DANTAS, R.A.; SOUZA, A.M.; ALVES, D.L.; CORDEIRO, S.C.; BARBOSA, C.D.S.; FERNANDES, E.B.; AZEVEDO, A.P.; Motivos de abandono aos antirretrovirais entre pacientes internados em um hospital de referência em doenças infecto contagiosas do Amazonas. Revista Feridas • 2021; 09 (49) 1754-1761. file:///C:/Users/33822280259/Downloads/diagramadora,+REVISTA+FERIDAS+-+ED.49+ARTIGO+1.pdf

OLIVEIRA SR et al. Associação entre suporte social com adesão ao tratamento antirretroviral em pessoas vivendo com o HIV. Rev Gaúcha Enferm. 2020;41:e20190290

SOUZA HC et al. Análise da adesão ao tratamento com antirretrovirais em pacientes com HIV/AIDS. Rev Bras Enferm [Internet]. 2019;72(5):1361-9

SANTOS VF et al. Uso do telefone para adesão de pessoas vivendo com HIV/AIDS à terapia antirretroviral: revisão sistemática. Ciência & Saúde Coletiva, 24(9):3407-3416, 2019

SANTOS ACF et al. Perfil epidemiológico dos pacientes internados por HIV no Brasil. REAS/EJCH | Vol.Sup.n.48| e3243|DOI: https://doi.org/10.25248/reas.e3243.2020

TAQUETTE SR, RODRIGUES AO, BORTOLOTTI LR. Percepção de pacientes com AIDS diagnosticada na adolescência sobre o aconselhamento pré e pós-teste HIV realizado. Ciência & Saúde Coletiva, 22(1):23-30, 2017.

ZEPEDA KGM et al. Gerência do cuidado de enfermagem em HIV/aids na perspectiva paliativa e hospitalar. Rev Bras Enferm [Internet]. 2019;72(5):1308-15. 1.

CHEHAB, G. et al. Medical adherence in patients with systemic lupus erythematosus in Germany: predictors and reason for non-adherence – a cross-sectional analysis of the LuLa-cohort. Lupus, v. 27, n. 10, p. 1652-1660, 2018

COSTEDOAT-CHALUMEAU, N.; TAMIROU, F.; PIETTE, J.C. Treatment adherence in systemic lupus erythematosus and rheumatoid arthritis: time to focus on this important issue. Editorial. Rheumatology, 2017.

COSTEDOAT-CHALUMEAU, N. et al. A prospective international study on adherence to treatment in 305 patients with flaring SLE: assessment by drug levels and by self-administered questionnaires. Clinical Pharmacology & Therapeutics, v. 103, n. 6, p. 1074-1082, 2018

FARINHA, F. et al. Concerns of patients with systemic lupus erythematosus and adherence to therapy – a qualitative study. Patient Preference and Adherence, v. 11, p. 1213-1219, 2017.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright (c) 2024 CLARINE CRISTINA BARROS SORIANO, DANIELA DA SILVA BRASIL, MANUELA SILVA DE NEGREIROS CASTRO, YAGO VINICIUS SPATOLA ALMEIDA, ELLEN FIGUEIRA ESCOSSIO, THALES SILVESTRE NETO, GRACIELLI KERPEL ROTILLI, DAIANE TEIXEIRA DE SOUSA MARINHO, JESSICA CARVALHO SANTOS, PAULA CRISTINA RIOS RODRIGUEZ, ARIMATÉIA PORTELA DE AZEVEDO